DE202018100463U1 - Cosmetic or pharmaceutical preparation for skin care and for the prophylaxis of muscle cramps - Google Patents

Abstract

Topically applied cosmetic or pharmaceutical preparation for skin care and for the prophylaxis of muscle cramps containing an extract of wormwood herb.

Description

The present invention relates to a topically applied cosmetic or pharmaceutical preparation for skin care and for the prophylaxis of muscle cramps containing an extract of wormwood herb.

Skin care is part of body care and, in a broader sense, involves cleansing and treating the skin with the aim of preserving the natural protective mechanisms and the health of the skin and improving general well-being. Skin care products are cosmetic or medicinal preparations for the care and replenishment of stressed skin and for the post-treatment or prophylaxis of acute dermatoses. Commonly used active ingredients are, for example, urea, dexpanthenol, allantoin and various oils and fats.

A muscle spasm is a sudden, painful involuntary muscle contraction, which usually lasts only briefly. A spasm can be favored or triggered by various factors. As a mostly benign and many people known phenomenon, muscle cramps can occur after overstraining individual muscle groups and electrolyte disturbances. Frequently nocturnal leg cramps, also called Krampussyndrom, or also so-called Schreibkrmpens of the hand musculature. They can be alleviated by relaxation exercises or in some cases prevented by the supply of magnesium. Partly, a deficiency of sodium chloride (table salt) is the cause of convulsions. Sodium chloride is increasingly secreted by sweat during athletic activity. A compensation is necessary because an electrolyte deficiency compared to the extracellular space can affect the function of the nerve cells.

Likewise, a lack of potassium (for example, by excessive exudation) contribute to the development of convulsions. As an important electrolyte, it is important for the control of muscle activity.

As a prophylaxis against the occurrence of muscle cramps, the intake of sufficient electrolytes is recommended, among others, in sports medicine. This can e.g. in the form of fruit or special isotonic drinks. Also, preventive stretching exercises are designed to help prevent muscle spasms. All proposed prophylactic measures have in common, however, that they are not reliable and not work for all concerned. For example, convulsions also occur in people whose electrolyte balance shows no deficits or displacements. Athletes, in particular, are frequently affected by muscle cramps, with calf cramps being of particular importance since they can also be dangerous beyond acute pain. For example, when a convulsive swimmer can no longer stay afloat or a runner or soccer player falls over due to a calf cramp.

There is therefore a significant need for means of preventing muscle spasms.

Surprisingly, it has been found that the topical application of a suitably formulated extract of wormwood herb has a skin-caring effect and prevents the development of muscle cramps.

The present invention therefore relates to a topical cosmetic or pharmaceutical preparation for skin care and for the prophylaxis of muscle cramps, which contains an extract of wormwood herb.

An extract of worm fern was widely used to treat worm diseases at the beginning of the 20th century. In the 1950s, the extract was banned even for some cases of intoxication (WHO / FAO / OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis / Cysticercosis, 2005).

Therefore, it was not to be expected that the extract toxic in case of internal administration would turn out to be a dermatologically acceptable skin care product and to prevent muscle spasms.

In the sense of the present invention, herbaceous constituents (stems and in particular leaves) are understood as meaning plants from the family of the Dryopteridaceae (worm fern plants), in particular the genus Dryopteris (worm ferns), particularly preferably the species Dryopteris filix-mas.

It should be noted in the context of the compositions according to the invention that all of the abovementioned relative or percentages by weight are to be selected such that they sum up in the composition according to the invention, including all components or ingredients or additives or components. Always supplement excipients to 100% or 100% by weight. However, this goes without saying for the skilled person.

In addition, it is true that the person skilled in the art may deviate from the numbers, ranges, weights and quantities given below, based on the application or the individual case, without departing from the scope of the present invention.

It goes without saying that embodiments, embodiments, advantages and the like, which are given below for purposes of avoiding repetition only to one aspect of the invention, also apply accordingly in relation to the other aspects of the invention.

A preferred preparation according to the invention contains wormwood herb extract in an effective, in particular in cosmetically and / or pharmaceutically effective amount.

A preparation according to the invention preferably contains a total content of worm-fern extract of 1 to 80% by weight, in particular 15 to 50% by weight, preferably 25 to 40% by weight, particularly preferably 35% by weight. Particularly suitable according to the invention is an oily extract of the worm fern with a ratio of drug to extractant of 1 to 3:35, in particular 2:35.

• • 1 bis 10%, insbesondere 5% eines Emulgators, vorzugsweise Isoamyl Laurate,
• • 5 bis 15%, insbesondere 10% eines Konsistenzgebers (Ölverdickers), vorzugsweise hydriertes Pflanzenöl,
• • 1 bis 4%, insbesondere 2,5% eines Co-Emulgators, vorzugsweise Glyceryl Oleate,
• • 10 bis 60%, insbesondere 43% eines ersten Pflanzenöls, vorzugsweise Rapsöl,
• • 1 bis 10%, insbesondere 3,94% eines zweiten Pflanzenöls, vorzugsweise Kokosöl,
• • 0,001 bis 5%, insbesondere 0,010% eines Korblütlerextraktes, vorzugsweise Ringelblumenextrakt und
• • 0,1 bis 3%, insbesondere 0,5% Tocoperol.

Particularly preferably, a preparation according to the invention contains, in addition to the worm fern extract, approximately

• 1 to 10%, in particular 5% of an emulsifier, preferably isoamyl laurate,
• 5 to 15%, in particular 10% of a bodying agent (oil thickener), preferably hydrogenated vegetable oil,
• 1 to 4%, in particular 2.5% of a coemulsifier, preferably glyceryl oleate,
• 10 to 60%, in particular 43% of a first vegetable oil, preferably rapeseed oil,
• 1 to 10%, in particular 3.94% of a second vegetable oil, preferably coconut oil,
• 0.001 to 5%, in particular 0.010% of a Korblütlerextraktes, preferably marigold extract and
• • 0.1 to 3%, especially 0.5% tocoperol.

Advantageously, the preparation according to the invention gives a more pleasant feel to the skin, in particular with dry skin, a cosmetic improvement of the appearance of the skin and a reduction in the occurrence of muscle cramps, both with regard to the frequency of occurrence and with regard to the intensity of the convulsions. In particular, intensity and number of calf cramps can be reduced by means of the preparation according to the invention.

The preparation according to the invention can be formulated in any form that appears suitable to the person skilled in the art, but it is particularly preferred that it be formulated as an ointment or gel.

Another object of the present invention is the use of a preparation according to the invention in the field of pharmacy, or medicine for the prophylactic treatment of seizures and in particular Wadenkrampfneigungen.

Another object of the present invention is a process for the preparation of a composition according to the invention for skin care and for the prophylaxis of muscle cramping, which comprises mixing an extract of wormwood herb as described for the preparations according to the invention with cosmetically or pharmacologically suitable and acceptable carriers ,

The extract of wormwood herb is preferably incorporated or incorporated in the context of the present invention as a component in a cosmetic or pharmaceutical preparation.

Depending on the nature of the formulation, the pharmaceutical preparation of the invention may contain at least one further auxiliary or additive, such. As oils, protective colloids, plasticizers, antioxidants and / or emulsifiers. In the case of a dispersion, especially in the case of a suspension or emulsion, it is advantageous, in addition to a physiologically acceptable oil such as sesame oil, corn oil, cottonseed oil, soybean oil or peanut oil, esters of medium-chain fatty acids or fish oils such as mackerel, sprat or salmon oil use.

To increase the stability of the active ingredient against oxidative degradation, it is advantageous to use stabilizers such as α-tocopherol, β-tocopherol, γ-tocopherol, δ-tocopherol, gallates, diethylhexyl syringylidenemalonate, ascorbic acid and its esters, catechol, carnosic acid, genistein, lipoic acid, kaempferol , Caffeic acid, oleuropein, hydroxytyrosol, quercetin, rosmarinic acid, sinapinic acid, bis-ethylhexyl hydroxydimethoxy benzyl malonates, tetrasodium glutamate diacetate, sodium polyphosphate, epigallocatechin gallate, beta-carotene, ectoine or lycopene.

The dosage and duration of use of the preparation according to the invention can be suitably adjusted and varied by the person skilled in the art.

The possible dosage forms of the preparation according to the invention include topical or local application forms in the form of patches, rinses, shampoos, foam or shower baths, gels, ointments, creams, lotions, stick preparations, powders, pastes and sprays, and also as aerosol applications of the aforementioned application forms.

The cosmetic and pharmaceutical preparations according to the invention, such as hair shampoos, hair lotions, bubble baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compounds, stick preparations, powders or ointments can - depending on the nature of the formulation As adjuvants and additives mild surfactants, oil bodies, emulsifiers, superfatting agents, pearlescent waxes, bodying agents, thickeners, polymers, silicone compounds, fats, waxes, stabilizers, biogenic agents, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, UV protection factors, antioxidants, Hydrotropes, preservatives, insect repellents, self-tanning, solubilizers, perfume oils, dyes and the like.

Typical examples of suitable mild, i. particularly skin-compatible surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, α-olefinsulfonates, ether carboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines and / or protein fatty acid condensates, the latter preferably based on wheat proteins.

Examples of oil bodies are Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C ₆ -C ₃₂ fatty acids with linear C ₆ -C ₃₂ fatty alcohols, esters of branched C ₆ -C ₁₃ carboxylic acids with linear C ₆ -C ₃₂ fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristylisostearat, myristyl, Myristylbehenat, Myristylerucat, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearylmyristat, stearyl palmitate, stearyl stearate, Stearylisostearat, stearyl oleate, stearyl behenate, Stearylerucat, isostearyl, isostearyl palmitate, Isostearylstearat, isostearyl isostearate, Isostearyloleat, isostearyl behenate, Isostearyloleat, oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, Oleylbehenat, oleyl erucate, behenyl myristate, behenyl palmitate, behenyl, Behenylisostearat, behenyl oleate, behenyl behenate, behenyl erucate, Erucylm yristate, erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl erucate.

In addition, esters of linear C ₆ -C ₃₂ fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of hydroxycarboxylic acids with linear or branched C ₆ -C ₃₂ fatty alcohols, in particular dioctyl malates, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimerdiol or trimer triol) and / or Guerbet alcohols, triglycerides based on C ₆ -C ₁₀ fatty acids, liquid mono- / di- / Triglyceridmisungen based on C ₆ -C ₁₈ fatty acids, esters of C ₆ C ₃₂ fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, in particular benzoic acid, esters of C ₂ -C ₁₂ dicarboxylic acids with linear or branched alcohols having 1 to 32 carbon atoms or polyols having 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils , branched primary alcohols, substituted cyclohexanes, linear and branched C ₆ -C ₃₂ fatty alcohol carbonates, Guerbet carbonates, esters of benzoic acid with lin earen and / or branched C ₆ -C ₃₂ alcohols (such as Finsolv ^® TN), linear or branched, symmetrical or asymmetrical dialkyl ethers having 6 to 32 carbon atoms per alkyl group, ring opening products of epoxidized Fettsäureestern with polyols, silicone oils and / or aliphatic or naphthenic Hydrocarbons, such as. Squalane, squalene, hemisqualan or dialkylcyclohexanes.

• (1) Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/ oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 32 C-Atomen, an Fettsäuren mit 12 bis 32 C-Atomen, an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe sowie Alkylamine mit 8 bis 32 Kohlenstoffatomen im Alkylrest;
• (2) C_12/18-Fettsäuremono- und -diester von Anlagerungsprodukten von 1 bis 30 Mol Ethylenoxid an Glycerin;
• (3) Glycerinmono- und -diester und Sorbitanmono- und -diester von gesättigten und ungesättigten Fettsäuren mit 6 bis 32 Kohlenstoffatomen und deren Ethylenoxidanlagerungsprodukte;
• (4) Alkyl- und/oder Alkenylmono- und -oligoglycoside mit 8 bis 32 Kohlenstoffatomen im Alk(en)ylrest und deren ethoxylierte Analoga;
• (5) Anlagerungsprodukte von 15 bis 60 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;
• (6) Polyol- und insbesondere Polyglycerinester;
• (7) Partialester auf Basis linearer, verzweigter, ungesättigter bzw. gesättigter C_6/32-Fettsäuren, Ricinolsäure sowie 12-Hydroxystearinsäure und Glycerin, Polyglycerin, Pentaerythrit, Dipentaerythrit, Zuckeralkohole (z.B. Sorbit), Alkylglucoside (z.B. Methylglucosid, Butylglucosid, Laurylglucosid) sowie Polyglucoside (z.B. Cellulose);
• (8) Mono-, Di- und Trialkylphosphate sowie Mono-, Di- und/oder Tri-PEG-alkylphosphate und deren Salze;
• (9) Wollwachsalkohole;
• (10) Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;
• (11) Mischester aus Pentaerythrit, Fettsäuren, Citronensäure und Fettalkohol gemäß DE 1165574 PS und/oder Mischester von Fettsäuren mit 6 bis 32 Kohlenstoffatomen, Methylglucose und Polyolen, vorzugsweise Glycerin oder Polyglycerin,
• (12) Polyalkylenglycole sowie
• (13) Glycerincarbonat.

Examples of suitable emulsifiers are nonionic surfactants from at least one of the following groups:

• (1) addition products of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide to linear fatty alcohols having 8 to 32 carbon atoms, to fatty acids having 12 to 32 carbon atoms, to alkylphenols having 8 to 15 carbon atoms in the Alkyl group and alkylamines having 8 to 32 carbon atoms in the alkyl radical;
• (2) C _12/18 fatty acid _mono- and diesters of addition products of 1 to 30 moles of ethylene oxide with glycerol;
• (3) glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids of 6 to 32 carbon atoms and their ethylene oxide addition products;
• (4) alkyl and / or alkenyl mono- and oligoglycosides having 8 to 32 carbon atoms in the alk (en) yl radical and their ethoxylated analogs;
• (5) addition products of 15 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil;
• (6) polyol and especially polyglycerol esters;
• (7) _{partial esters} based on linear, branched, unsaturated or saturated C _6/32 fatty acids, ricinoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, pentaerythritol, dipentaerythritol, sugar alcohols (eg sorbitol), alkyl glucosides (eg methyl glucoside, butyl glucoside, lauryl glucoside) as well as polyglucosides (eg cellulose);
• (8) mono-, di- and trialkyl phosphates and mono-, di- and / or tri-PEG-alkyl phosphates and their salts;
• (9) wool wax alcohols;
• (10) polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives;
• (11) mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE 1165574 PS and / or mixed esters of fatty acids having 6 to 32 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol,
• (12) polyalkylene glycols as well
• (13) Glycerol carbonate.

The addition products of ethylene oxide and / or of propylene oxide to fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters and sorbitan mono- and diesters of fatty acids or to castor oil are known, commercially available products.

These are homolog mixtures whose mean degree of alkoxylation corresponds to the ratio of the molar amounts of ethylene oxide and / or propylene oxide and substrate with which the addition reaction is carried out. C _12/18 fatty acid _mono- and diesters of addition products of ethylene oxide with glycerol are made DE 2024051 PS known as a refatting agent for cosmetic preparations.

Alkyl and / or alkenyl mono- and oligoglycosides, their preparation and their use are known in the art. They are prepared in particular by reacting glucose or oligosaccharides with primary alcohols having 8 to 18 carbon atoms. With regard to the glycoside radical, both monoglycosides in which a cyclic sugar residue is glycosidically linked to the fatty alcohol and oligomeric glycosides having a degree of oligomerization of preferably approximately 8 are suitable. The degree of oligomerization is a statistical mean, which is based on a homolog distribution typical for such technical products.

Typical examples of suitable polyglycerol esters are Polyglyceryl-2 Dipolyhydroxystearate (Dehymuls ^® PGPH), Polyglycerin-3-Diisostearate (Lameform ^® TGI), Polyglyceryl-4 Isostearate (Isolan ^® GI 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan ^® PDI), Polyglyceryl-3 methylglucose Distearate (Tego Care ^® 450), Polyglyceryl-3 Beeswax (Cera Bellina ^®), Polyglyceryl-4 Caprate (polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl ether (Chimexane ^® NL), Polyglyceryl -3 Distearate (Cremophor ^® GS 32) and Polyglyceryl polyricinoleates (Admul ^® WOL 1403), polyglyceryl dimerates Isostearate and mixtures thereof.

Furthermore, zwitterionic surfactants can be used as emulsifiers. Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammoniumglycinate, for example Kokosalkyldimethylammoniumglycinat, N-acylaminopropyl-N, N-dimethylammoniumglycinate, for example Kokosacylaminopropyldimethylammoniumglycinat, and 2-alkyl-3-carboxylmethyl-3-hydroxyethylimidazoline each having 8 to 18 carbon atoms in the alkyl or acyl group and the Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. Particularly preferred is the fatty acid amide derivative known under the CTFA name Cocamidopropyl Betaine. Also suitable emulsifiers are ampholytic surfactants. Ampholytic surfactants are understood as meaning those surface-active compounds which, apart from a C _8/18 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO ₃ H group and are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N- Alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C _12/18 acylsarcosine. In addition to the ampholytic, quaternary emulsifiers are also suitable, with those of the esterquat type, preferably methyl-quaternized difatty acid triethanolamine ester salts, being particularly preferred.

As superfatting agents, substances such as lanolin and lecithin as well as polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used, the latter also serving as foam stabilizers.

Suitable pearlescing waxes are, for example: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polybasic, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 32 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which in total have at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring-opening products of olefin epoxides having 12 to 32 carbon atoms with fatty alcohols having 12 to 32 carbon atoms and / or polyols having 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.

As consistency factors are primarily fatty alcohols or hydroxy fatty alcohols having 12 to 32 and preferably 16 to 18 carbon atoms and in addition partial glycerides, fatty acids or hydroxy fatty acids into consideration. Preference is given to a combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates.

Suitable thickening agents are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, furthermore higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, (eg Carbopols ^® from Lubrizol or Synthalens ^® of Sigma), polyacrylamides, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as ethoxylated fatty acid glycerides, esters of fatty acids with polyols for example pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates having a narrowed homolog distribution or alkyl oligoglucosides, and electrolytes such as sodium chloride and ammonium chloride.

Suitable cationic polymers are for example cationic cellulose derivatives, for example, a quaternized hydroxyethylcellulose obtainable under the name Polymer JR 400 ^® from Amerchol, cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, for example Luviquat ^® (BASF) , condensation products of polyglycols and amines, quaternized collagen polypeptides, for example lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat® ^® L / Grunau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, for example, amodimethicone, copolymers of adipic acid and dimethylaminohydroxypropyl diethylenetriamine (Cartaretine ^® / Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat ^® 550 / Chemviron), polyaminopolyamides, as described for example in FR 32 2252840 A and their crosslinked water-soluble polymers, cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline distributed, condensation products of dihaloalkylene, such as dibromobutane with bis-dialkylamines, such as bis-dimethylamino-1,3-propane, cationic guar gum, such as Jaguar ^® CBS, Jaguar ^® C-17, Jaguar ^® C-16 of Celanese, quaternized ammonium salt polymers, for example Mirapol ^® A-15, Mirapol ^® AD-1, Mirapol ^® AZ-1 from Miranol.

Examples of anionic, zwitterionic, amphoteric and nonionic polymers are vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and their esters, uncrosslinked polyols crosslinked with polyols, acrylamidopropyltrimethylammonium chloride / acrylate Copolymers, octylacrylamide / methyl methacrylate / tert.butylaminoethylmethacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinylpyrrolidone, vinylpyrrolidone / vinyl acetate copolymers, vinylpyrrolidone / dimethylaminoethyl methacrylate / vinylcaprolactam terpolymers and optionally derivatized cellulose ethers and silicones in question.

Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl-modified silicone compounds which may be both liquid and resin-form at room temperature. Also suitable are simethicones, which are mixtures of dimethicones having an average chain length of from 200 to 300 dimethylsiloxane units and hydrogenated silicates. A detailed overview of suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976) ,

Typical examples of fats are glycerides, as waxes u.a. natural waxes, e.g. Candelilla wax, carnauba wax, Japan wax, esparto wax wax, cork wax, guaruma wax, rice germ oil wax, sugarcane wax, ouricury wax, montan wax, beeswax, shellac wax, spermaceti, lanolin (wool wax), crepe fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, microwaxes; chemically modified waxes (hard waxes), e.g. Montan ester waxes, Sasol waxes, Fischer-Tropsch waxes, hydrogenated jojoba waxes and synthetic waxes, such as e.g. Polyalkylene waxes and polyethylene glycol waxes in question.

As stabilizers, metal salts of fatty acids, e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.

Biogenic active ingredients are, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, deoxyribonucleic acid, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils, plant extracts and vitamin complexes.

Cosmetic deodorants (deodorants) counteract, cover or eliminate body odors. Body odors are caused by the action of skin bacteria on apocrine sweat, forming unpleasant-smelling degradation products. Accordingly, deodorants contain active ingredients which act as anti-sprouting agents, enzyme inhibitors, odor absorbers or odor maskers.

As germ-inhibiting agents, which are optionally added to the cosmetics of the invention, in principle all substances effective against gram-positive bacteria are suitable, such as. 4-hydroxybenzoic acid and its salts and esters, N- (4-chlorophenyl) -N'- (3,4-dichlorophenyl) urea, 2,4,4'-trichloro-2'-hydroxydiphenyl ether (triclosan), 4-chloro 3,5-dimethylphenol, 2,2'-methylene-bis (6-bromo-4-chlorophenol), 3-methyl-4- (1-methylethyl) phenol, 2-benzyl-4-chlorophenol, 3- (4 -Chlorophenoxy) -1,2-propanediol, 3-iodo-2-propynyl butylcarbamate, chlorhexidine, 3,4,4'-trichlorocarbanilide (TTC), antibacterial fragrances, thymol, thyme oil, eugenol, clove oil, menthol, mint oil, farnesol, phenoxyethanol , Glycerol monolaurate (GML), diglycerol monocaprinate (DMC), salicylic acid N-alkylamides such. Salicylic acid n-octylamide or salicylic acid n-decylamide.

Enzyme inhibitors can also be added to the cosmetics according to the invention. Suitable enzyme inhibitors are, for example, esterase inhibitors. These are preferably trialkyl such as trimethyl citrate, tripropyl, triisopropyl, tributyl citrate and especially triethyl citrate (Hydagen® ^® CAT, BASF AG). The substances inhibit the enzyme activity and thereby reduce odors. Further substances which are suitable as esterase inhibitors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterol, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, for example glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, adipic acid, Adipic acid monoethyl ester, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or diethyl tartrate, and zinc glycinate.

Suitable odor absorbers are substances that absorb and largely retain odor-forming compounds. They reduce the partial pressure of the individual components and thus also reduce their propagation speed. It is important that perfumes must remain undisturbed. Odor absorbers have no activity against bacteria. They contain, for example, as a main component of a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known in the art as "fixatives", such. B. Extracts of Labdanum or Styrax or certain Abietinsäurederivate. Odor maskers are fragrances or perfume oils which, in addition to their function as odor maskers, give the deodorants their respective scent. Examples of perfume oils are mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers, stems and leaves, fruits, fruit peel, roots, woods, herbs and grasses, needles and twigs, as well as resins and balsams. Furthermore, animal raw materials come into question, such as civet and Castoreum. Typical synthetic fragrance compounds are ester type products, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allylcyclohexyl propionate, styrallyl propionate and benzyl salicylate. For example, the ethers include Benzyl ethyl ether, to the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, Hydroxycitronellal, Lilial and Bourgeonal, to the ketones, for example, the Jonone and Methylcedrylketon to the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol , Linalool, phenylethylalcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance. Also essential oils of lower volatility, which are usually used as aroma components, are suitable as perfume oils, eg sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil. Preferably, bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, Sandelice, citron oil, tangerine oil, orange oil, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Sage oil, β-damascone, geranium oil Bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, fixolide NP, evernyl, iraldeine gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilate, irotyl and floramate alone or in mixtures.

• (a) adstringierende Wirkstoffe,
• (b) Ölkomponenten,
• (c) nichtionische Emulgatoren,
• (d) Coemulgatoren,
• (e) Konsistenzgeber,
• (f) Hilfsstoffe wie z. B. Verdicker oder Komplexierungsmittel und/oder
• (g) nichtwässrige Lösungsmittel wie z. B. Ethanol, Propylenglykol und/oder Glycerin.

Antiperspirants (antiperspirants) reduce the formation of sweat by influencing the activity of eccrine sweat glands and thus counteract underarm wetness and body odor. Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:

• (a) astringent agents,
• (b) oil components,
• (c) nonionic emulsifiers,
• (d) coemulsifiers,
• (e) bodybuilder,
• (f) adjuvants such as. B. thickener or complexing agent and / or
• (g) non-aqueous solvents such as. As ethanol, propylene glycol and / or glycerol.

• • entzündungshemmende, hautschützende oder wohlriechende ätherische Öle,
• • synthetische hautschützende Wirkstoffe und/oder
• • öllösliche Parfümöle.

Salts of aluminum, zirconium or zinc are especially suitable as astringent antiperspirant active ingredients. Such suitable antiperspirant active ingredients are, for example, aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. With propylene glycol-1,2. Aluminiumhydroxyallantoinat, aluminum chloride tartrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate and their complex compounds z. With amino acids such as glycine. In addition, antiperspirants may contain customary oil-soluble and water-soluble adjuvants in smaller amounts. Such oil-soluble auxiliaries may be, for example:

• • anti-inflammatory, skin-protecting or fragrant essential oils,
• • synthetic skin-protecting agents and / or
• • oil-soluble perfume oils.

Usual water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusters, e.g. Buffer mixtures, water-soluble thickeners, e.g. water-soluble natural or synthetic polymers such as e.g. Xanthan gum, hydroxyethyl cellulose, pectins, carrageenans, polyvinyl alcohols, alginates, cellulose, hyaluronic acid, polyvinylpyrrolidone or high molecular weight polyethylene oxides.

Climbazole, octopirox and zinc pyrithione can be used as anti-dandruff agents.

Typical film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or salts thereof and similar compounds.

Suitable swelling agents for aqueous phases are montmorillonites, clay minerals, pemulen and alkyl-modified carbopol types (Lubrizol). Other suitable polymers or swelling agents can the overview of R. Lochhead in Cosm.Toil. 108, 95 (1993) be removed.

• • 3-Benzylidencampher bzw. 3-Benzylidennorcampher und dessen Derivate, z.B. 3-(4-Methylbenzyliden)campher wie in der EP 0693471 B1 beschrieben;
• • 4-Aminobenzoesäurederivate, vorzugsweise 4-Dimethylamino)benzoesäure-2-ethylhexylester, 4-(Dimethylamino)benzoesäure-2-octylester und 4-(Dimethylamino)benzoesäureamylester;
• • Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester, 4-Methoxyzimtsäurepropylester, 4-Methoxyzimtsäureisoamylester 2-Cyano-3,3-phenylzimtsäure-2-ethylhexylester (Octocrylene);
• • Ester der Salicylsäure, vorzugsweise Salicylsäure-2-ethylhexylester, Salicylsäure-4-isopropylbenzylester, Salicylsäurehomomenthylester;
• • Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-methoxy-4‘-methylbenzophenon, 2,2‘-Dihydroxy-4-methoxybenzophenon;
• • Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzmalonsäuredi-2-ethylhexylester;
• • Triazinderivate, wie z.B. 2,4,6-Trianilino-(p-carbo-2‘-ethyl-1‘-hexyloxy)-1,3,5-triazin und Octyl Triazon, wie in der EP 0818450 A1 beschrieben oder Dioctyl Butamido Triazone (Uvasorb^® HEB);
• • Propan-1,3-dione, wie z.B. 1-(4-tert.Butylphenyl)-3-4‘methoxyphenyl)propan-1,3-dion;
• • Ketotricyclo(5.2.1.0)decan-Derivate, wie in der EP 0694521 B1 beschrieben.

Under UV sun protection factors are, for example, at room temperature, liquid or crystalline organic substances present (sunscreen) to understand, which are able to absorb ultraviolet rays and the absorbed energy in the form of longer-wave radiation, eg heat again. UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances are:

• • 3-Benzylidencampher or 3-Benzylidennorcampher and its derivatives, eg 3- (4-methylbenzylidene) camphor as in EP 0693471 B1 described;
• 4-aminobenzoic acid derivatives, preferably 4-dimethylamino) benzoic acid 2-ethylhexyl ester, 4- (dimethylamino) benzoic acid 2-octyl ester and 4- (dimethylamino) benzoic acid amyl ester;
• Esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
• Esters of salicylic acid, preferably 2-ethylhexyl salicylate, 4-isopropylbenzyl salicylate, homomenthyl salicylate;
• Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
• Esters of benzalmalonic acid, preferably di-2-ethylhexyl 4-methoxybenzmalonate;
• Triazine derivatives, such as 2,4,6-trianilino (p-carbo-2'-ethyl-1'-hexyloxy) -1,3,5-triazine and octyl triazone, as described in U.S. Pat EP 0818450 A1 Dioctyl Butamido Triazone or described (Uvasorb HEB ^®);
• Propane-1,3-diones such as 1- (4-tert-butylphenyl) -3-4'-methoxyphenyl) propane-1,3-dione;
• • Ketotricyclo (5.2.1.0) decane derivatives as described in U.S. Pat EP 0694521 B1 described.

• • 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylammonium-, Alkanolammonium- und Glucammoniumsalze;
• • Sulfonsäurederivate von Benzophenonen, vorzugsweise 2-Hydroxy-4-methoxybenzophenon-5-sulfonsäure und ihre Salze;
• • Sulfonsäurederivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornylidenmethyl)benzolsulfonsäure und 2-Methyl-5-(2-oxo-3-bornyliden)sulfonsäure und deren Salze.

Suitable water-soluble substances are:

• 2-phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts;
• Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
• Sulfonic acid derivatives of 3-Benzylidencamphers, such as 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) sulfonic acid and salts thereof.

As a typical UV-A filter in particular derivatives of benzoylmethane are suitable, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl 4'-methoxydibenzoylmethane (Parsol 1789), 1-phenyl-3- (4'-isopropylphenyl) -propane-1,3-dione, and enamine compounds as described in U.S.P. DE 19712033 A1 (BASF). Of course, the UV-A and UV-B filters can also be used in mixtures. In addition to the soluble substances mentioned, insoluble photoprotective pigments, namely finely dispersed metal oxides or salts, are also suitable for this purpose. Examples of suitable metal oxides are in particular zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof. As salts silicates (talc), barium sulfate or zinc stearate can be used. The oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics. The particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They may have a spherical shape, but it is also possible to use those particles which have an ellipsoidal or otherwise deviating shape from the spherical shape. The pigments can also be surface-treated, ie hydrophilized or hydrophobized. Typical examples are coated titanium dioxides, for example Titandioxid T 805 (Evonik) or Eusolex ^® T2000 (Merck). Suitable hydrophobic coating agents are in particular silicones and in particular trialkoxyoctylsilanes or simethicones. In sunscreens, so-called micro- or nanopigments are preferably used. Preferably, micronized zinc oxide is used. Further suitable UV sunscreen filters are the overview of P. Finkel in SOFW Journal 122, 543 (1996) refer to.

In addition to the two aforementioned groups of primary light stabilizers, it is also possible to use secondary light stabilizers of the antioxidant type which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates into the skin. Typical examples are amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocaninic acid) and their derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg anserine) , Chlorogenic acid and its derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (eg thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl) , Amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and Sulfoximinverbindungen (eg Buthioninsulfoximine, Homocysteinsulfoximin, Butioninsulfone, penta-, hexa-, Heptathioninsulfoximin) in very low tolerated dosages (eg pmol to mol / kg), further (metal) chelators (eg Hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (eg citric acid, lactic acid, malic acid), humic acid, bile acids, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (eg γ-linolenic acid, Linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (eg ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (eg vitamin E acetate), vitamin A and derivatives (vitamin Α-palmitate) and benzylic benzylic resin, rutinic acid and derivatives thereof, α-glycosylrutin, ferulic acid, furfurylideneglucitol, carnosine, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacetic acid, nordihydroguiaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and their derivatives Derivatives, superoxide dismutase, zinc and its derivatives (eg ZnO, ZnSO ₄ ) selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide) and the derivatives suitable for this purpose (salts, esters, Ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active substances.

• • Glycerin;
• • Alkylenglycole, wie beispielsweise Ethylenglycol, Diethylenglycol, Propylenglycol, Butylenglycol, Hexylenglycol sowie Polyethylenglycole mit einem durchschnittlichen Molekulargewicht von 100 bis 1.000 Dalton;
• • technische Oligoglyceringemische mit einem Eigenkondensationsgrad von 1,5 bis 10 wie etwa technische Diglyceringemische mit einem Diglyceringehalt von 40 bis 50 Gew.-%;
• • Methyolverbindungen, wie insbesondere Trimethylolethan, Trimethylolpropan, Trimethylolbutan, Pentaerythrit und Dipentaerythrit;
• • Niedrigalkylglucoside, insbesondere solche mit 1 bis 8 Kohlenstoffen im Alkylrest, wie beispielsweise Methyl- und Butylglucosid;
• • Zuckeralkohole mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Sorbit oder Mannit,
• • Zucker mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Glucose oder Saccharose;
• • Aminozucker, wie beispielsweise Glucamin;
• • Dialkoholamine, wie Diethanolamin oder 2-Amino-1,3-propandiol.

Hydrotropes such as, for example, ethanol, isopropyl alcohol, or polyols can also be used to improve the flow behavior. Polyols contemplated herein preferably have from 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols may contain other functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are

• • glycerin;
• Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol, and polyethylene glycols having an average molecular weight of 100 to 1,000 daltons;
• Technical Oligoglyceringemische with an intrinsic degree of condensation of 1.5 to 10 such as technical Diglyceringemische with a diglycerol content of 40 to 50 wt .-%;
• Methyolverbindungen, in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
• Lower alkyl glucosides, especially those having 1 to 8 carbons in the alkyl radical, such as, for example, methyl and butyl glucoside;
• Sugar alcohols having 5 to 12 carbon atoms, such as sorbitol or mannitol,
• • sugars having 5 to 12 carbon atoms, such as glucose or sucrose;
• • amino sugars, such as glucamine;
• Dialcohols, such as diethanolamine or 2-amino-1,3-propanediol.

Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Part A and B of the Cosmetics Regulation. Insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl Butylacetylaminopropionate in question, suitable as a self-tanner dihydroxyacetone or erythrulose.

As perfume oils are called mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (aniseed, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (macis, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, pines), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Furthermore, animal raw materials come into question, such as civet and Castoreum. Typical synthetic fragrance compounds are ester type products, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are known e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, benzylformate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate and benzylsalicylate. The ethers include, for example, benzyl ethyl ether, to the aldehydes e.g. the linear alkanals of 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones e.g. the ionones, ∞-isomethylionone and methylcedryl ketone; the alcohols include anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol; the hydrocarbons mainly include the terpenes and balsams. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance. Also, lower volatility volatile oils, which are most commonly used as aroma components, are useful as perfume oils, e.g. Sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil. Preferably, bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, Sandelice, citron oil, tangerine oil, orange oil, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Sage oil, β-damascone, geranium oil Bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, fixolide NP, evernyl, iraldeine gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllat, irotyl and floramate alone or in mixtures.

Dyes which may be used are the substances suitable and approved for cosmetic purposes, as described, for example, in the publication "Cosmetic Dyes" of the Dye Commission of the Deutsche Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, pp. 81-106 are compiled. These dyes are usually used in concentrations of 0.001 to 0.1 wt .-%, based on the total mixture.

The total amount of auxiliaries and additives may be from 1 to 90, preferably from 5 to 70,% by weight, particularly preferably from 10 to 35,% by weight, based on the preparation. The preparation of the cosmetic or pharmaceutical preparations can be carried out by conventional cold or hot processes with or without high pressure homogenization; It is preferable to work according to the phase inversion temperature method.

Example:
The following recipe example describes the invention without, however, limiting it. Unless indicated otherwise, all amounts, proportions and percentages are based on the weight and the total amount or on the total weight of the preparation. phase raw material INCI supplier Amount [%] fat phase Dermofeel Sensolv Isoamyl laurate Dr. Straetmans 5 Dermofeel viscolid Hydrogenated Vegetable Oil Dr. Straetmans 10 Dermofeel PO Glyceryl Oleate Dr. Straetmans 2.5 rapeseed oil Brassica Campestris (Rapeseed) Seed Oil Völpker Spezialprodukte GmbH 43 Extr.Dryopteris filix mas oleosum Brassica Campestris (Rapeseed) Seed Oil + Dryopteris Filix-Mas Leaf Extract Gehrlicher GmbH 35 Coconut oil pressed kba Coconut Nucifera (Coconut) Oil Henry Lamotte Oils GmbH 3.94 Marigold Flower CO2 Extract 018.002 Calendula Officinalis Flower Extract Flavex 0.01 extra phase Lemongrass Cochin 75% Cymbopogon Schoenanthus Oil eskamint Schierholz GmbH 0.05 Dermofeel Toco 50 non GMO Tocopherol + Helianthus Annuus (Sunflower) Seed Oil Dr. Straetmans 0.5 Total quantity: 100

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• DE 1165574 [0031]
• DE 2024051 [0033]
• FR 322252840 A [0041]
• EP 0693471 B1 [0057]
• EP 0818450 A1 [0057]
• EP 0694521 B1 [0057]
• DE 19712033 A1 [0059]

Cited non-patent literature

• et al. in Cosm.Toil. 91, 27 (1976) [0043]
• R. Lochhead in Cosm.Toil. 108, 95 (1993) [0056]
• P. Finkel in SOFW Journal 122, 543 (1996) [0059]
• "Cosmetic Colorants" of the Dye Commission of the Deutsche Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, pp. 81-106 [0064]

Claims (7)

 Topically applied cosmetic or pharmaceutical preparation for skin care and for the prophylaxis of muscle cramps containing an extract of wormwood herb. A preparation according to claim 1, characterized in that the extract of wormwood herb is an extract of the herbaceous constituents of plants of the family of the Dryopteridaceae, in particular of the genus Dryopteris, particularly preferably of the species Dryopteris filix-mas. A preparation according to claim 1 or 2, characterized in that the extract of worm-hair weed is an oily extract, preferably with a ratio of drug to extractant of 1 to 3 to 35, in particular 2 to 35. Preparation according to one of the preceding claims, characterized in that it contains a total content of worm-fern extract of from 1 to 80% by weight, in particular 15 to 50% by weight, preferably 25 to 40% by weight, particularly preferably 35% by weight. Preparation according to one of the preceding claims, characterized in that it contains, in addition to the worm fern extract, about 1 to 10%, in particular 5% of an emulsifier, preferably isoamyl laurate, 5 to 15%, in particular 10% of a consistency indicator (oil thickener), preferably hydrogenated Vegetable oil, 1 to 4%, in particular 2.5% of a co-emulsifier, preferably glyceryl oleate, 10 to 60%, in particular 43% of a first vegetable oil, preferably rapeseed oil, 1 to 10%, in particular 3.94% of a second vegetable oil, preferably coconut oil, • 0.001 to 5%, in particular 0.010% of a Korblütlerextraktes, preferably marigold extract and • 0.1 to 3, in particular 0.5% tocoperol. Contains. Preparation according to one of the preceding claims, characterized in that it is present as an ointment or gel.  Use of a preparation as described in claims 1 to 6, in the field of pharmacy or medicine for the prophylactic treatment of convulsions and in particular calvarial tendencies.